Head to head
Centene vs UnitedHealth
Side-by-side on the measures that matter, with a plain-English read. Full detail: CNC · UNH
CNC
Centene
63.78-2.74%
1-year price shape — +83% over the period
Quant Rating C · 95/100
vs
UNH
UnitedHealth
339.85+2.84%
1-year price shape — +11% over the period
Quant Rating D · 55/100
1-year performance, rebased to 100
UnitedHealth edges it on the scoreable measures. UnitedHealth trades cheapest on trailing earnings; UnitedHealth pays the highest dividend yield; UnitedHealth earns the most per share.
| CNC | UNH | |
|---|---|---|
| Snapshot | ||
| Sector | -- | Healthcare Plans |
| Last price | 63.78 | 339.85 |
| Change today | -2.74% | +2.84% |
| 1-year return | +83.1% | +11.3% |
| Market cap | $31.58B | $304.51B |
| 52-week range | 31.63 – 78.08 | 252.95 – 458.79 |
| Valuation | ||
| P/E (TTM) | 21.92 | 19.40 |
| P/E percentile, own 5-yr range | 65th | 41st |
| P/B | 1.42 | 3.10 |
| Dividend yield | 0.00% | 2.67% |
| Profitability & growth | ||
| EPS (TTM) | -13.53 | 13.23 |
| Net profit (TTM) | $-6.70B | $11.85B |
| Revenue (TTM) | $203.90B | $449.66B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | +1.9% | -0.4% |
| Gross margin | 7.8% | 19.8% |
| Operating margin | 0.7% | 5.3% |
| Net margin | 0.7% | 3.5% |
| Free cash flow (TTM) | $3.94B | $22.83B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 100.6% | 88.8% |
| Insider activity (12mo) | 28 buy / 16 sell | 44 buy / 5 sell |
| Short interest (% of float) | 2.1% | 1.6% |
| Analyst consensus | 43% buy / 57% hold (14) | 88% buy / 12% hold (17) |
| Analyst price target | $78 (+22%) | $485 (+43%) |
| StockVane view | ||
| StockVane Quant Rating | C (95) | D (55) |
| Company | ||
| Employees | 61,100 | 390,000 |
| Founded | 1984 | 1977 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.